000 01529 a2200469 4500
005 20250514072121.0
264 0 _c20030731
008 200307s 0 0 eng d
022 _a0250-7005
040 _aNLM
_beng
_cNLM
100 1 _aHoopmann, Markus
245 0 0 _aHER-2/neu determination in blood plasma of patients with HER-2/neu overexpressing metastasized breast cancer: a longitudinal study.
_h[electronic resource]
260 _bAnticancer research
_c
300 _a1031-4 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aBiomarkers, Tumor
_xblood
650 0 4 _aBreast Neoplasms
_xpathology
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aLongitudinal Studies
650 0 4 _aLymphatic Metastasis
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aPredictive Value of Tests
650 0 4 _aReagent Kits, Diagnostic
650 0 4 _aReceptor, ErbB-2
_xblood
650 0 4 _aReceptors, Estrogen
_xanalysis
650 0 4 _aRetrospective Studies
650 0 4 _aTime Factors
650 0 4 _aTrastuzumab
700 1 _aNeumann, Rainer
700 1 _aTanasale, Thérese
700 1 _aSchöndorf, Thomas
773 0 _tAnticancer research
_gvol. 23
_gno. 2A
_gp. 1031-4
999 _c12603667
_d12603667